Voluntis gets FDA nod for its Oleena cancer management product

18:38 EDT 7 Aug 2019 | MedCity News

The company’s software acts as an aid for cancer patients by helping users self-manage their disease symptoms and allow for remote monitoring by clinicians through mobile and web technologies.

Original Article: Voluntis gets FDA nod for its Oleena cancer management product

More From BioPortfolio on "Voluntis gets FDA nod for its Oleena cancer management product"